Robert H. Resis provides useful strategies for petitioners in inter partes review proceedings in biotechnology and pharmaceutical patents in Part II of his two-part series in BNA’s Patent, Trademark and Copryight
Robert H. Resis provides useful strategies for patent owners in inter partes review proceedings in biotechnology and pharmaceutical patents in Part I of his two-part series in BNA’s Patent, Trademark
Ernest V. Linek discusses Merck’s unsuccessful move to invalidate a Bristol-Myers Squibb patent covering metastatic skin cancer treatment in Life Sciences Intellectual Property Review. In his article, Mr. Linek points out that
On April 5, 2016, the U.S. District Court for the District of Nevada entered judgment of no infringement in a patent infringement suit filed by Rembrandt Gaming Technologies, LP against
Darrell G. Mottley discusses the D.C. Bar’s Global Legal Practice Task Force and its efforts to study how globalization impacts the practice of law in Washington Lawyer. He also discusses
On February 17, 2016, Banner & Witcoff filed suit on behalf of client Nike, Inc., against Chinese footwear manufacturer Fujian Bestwinn for selling numerous models of shoes that infringe at
Neil Ziegman and NPZ Inc. recently requested rehearing of a Feb. 24 Patent Trial and Appeal Board decision denying a petition for inter partes review of inventor Carlis Stephens’ patent
Joseph M. Potenza has received the 2015-2016 Charles Fahy Distinguished Adjunct Professor Award from the Georgetown University Law Center. The award, which is named after the noted Georgetown Law alumnus who
R. Gregory Israelsen discusses the potential impact of the “Venue Equity and Non-Uniformity Elimination Act” or VENUE Act, introduced in the Senate on March 17, in Law360. Mr. Israelsen says the
In its article, “Law360 Reveals Largest IP Boutiques,” Law360 names Banner & Witcoff as one of the largest intellectual property boutique law firms in 2016. Law360 also points out that Banner &
